tetracycline as control inhibitors, monoketo-organomycin and cystaurimycin were found to inhibit protein synthesis in vitro by inhibiting peptidyl transferase of ribosomes. In marked contrast, this enzyme was activated, as also was protein synthesis, by their performic acidoxidized modifications. It was thus suggested that the growth inhibitory effects of the latter compounds might be due to their interference in other metabolic activities of the above test organism.
The results obtained are discussed in light of the chemical similarities or differences existing between the compounds investigated.
Studies on monoketo-organomycin (MKOM)1) revealed that this antibiotic is, through partial enzymic digestion, converted to the broad spectrum substance cystaurimycin (CYST) and that performic acid oxidation of these compounds appreciably improved their antimicrobial activities2). In spite of the close chemical similarities between these compounds, they showed differences in their chromatographic and electrophoretic behaviour as well as their antimicrobial activities2).
The present study was made to obtain more information about the functional relationship and mode of action of these compounds. Puromycin with its known mode of action3~5) was used to elucidate the mechanisms of action of the present compounds. Chlorotetracycline and chloramphenicol were used as control inhibitors.
Materials and Methods
Preparations of MKOM, CYST and their performic acid oxidation products are those reported by IMAM1) and by IMAM and K0NTZEL2) .
Growth Inhibitory Studies
In growth inhibitory experiments each substance was dissolved in phosphate buffer, pH 7.9, and serially diluted in I ml aliquots. To these volumes 4-ml portions of brain heart infusion broth (Difco), previously inoculated with the test organism, were added and the cultures were incubated at 37°C for 2 days. The maximum tolerated concentration (MTC) of each substance was recorded. The bacterial growth was related to the concentration of a given compound and was determined by measuring the Correspondence to: Dr. GAMAL M. IMAM, Rohnsterrassen 10, 3400-Gi ttingen, West-Germany (BRD). 936 THE JOURNAL OF ANTIBIOTICS SEPT. 1979 amount of 2-day bacterial mass spectrophotometrically at 660 nm using a Zeiss spectrophotometer. Separate resistant cultures of Escherichia coli NCTC 6820 to each of the 4 compounds were made by a series of transfers in brain heart infusion broth to which increasing amounts of the respective material was added. At each transfer, each mutant was tested for the simultaneous development of resistance to the other substances.
2. Effects on Ribosomal Peptidyl Transferase Activity Escherichia coli NCTC 6820 was grown on DAVIS minimal growth mediums'. The cultures were incubated at 37°C with shaking (250 r.p.m.) and the cells were harvested during the exponential phase, washed twice with 5 mm Tris-HCl of pH 7.0 containing 10 mm magnesium acetate and stored frozen until required. Crude extracts were prepared4) and diluted to 12 mg/ml ribosomes. The techniques adopted for the preparation of ribosome-free supernatant fraction and the reaction mixture for radioactive amino acid incorporation in protein and the conditions used for the puromycin reaction were those described by CANNON 4).
Results and Discussion
Conversion of MKOM into CYST and their performic acid oxidation was performed as described2) according to the following scheme:
Gly-Phe-Glu-Cys-(X)- Taurine Despite the close chemical similarities, particularly those existing between each given compound and its ox-form, previous results showed differences in their growth inhibitory activities2). The concept of biological specificity suggested that bacteria might exist in nature whose growth could be inhibited by one of these substances but not the others. Such a property should thus be associated with those parts of the molecule which are structurally different. The results of this survey (Table 1) Staphylococcus aureus D6 could be, however, observed but the latter organism was more sensitive to ox-CYST than the former.
The results obtained in case of E. coli NCTC 6820 are of especial interest because of the large differences in its response to the inhibitory effects of the compounds tested (Table 1) . Thus separate resistant cultures of this organism to each of the 4 compounds were prepared and tested for the simultaneous development of resistance to the other substances by use of the cross-resistance technique.
The basis of this method lies in the assumption that related antibiotics or those with similar chemical composition exert their growth inhibitory action through the same or closely similar groupings in their those of ox-MKOM and ox-CYST is the presence or absence of the N-terminal portion (see the above scheme) and since those lacking this portion, namely CYST and ox-CYST, are still biologically active (Table 1) , it is thus logical to conclude that this portion constitutes neither a structural nor a fundamental part of the biologically active moiety in MKOM or its ox-form. Furthermore, that CYST and ox-CYST were toxic to the growth of MKOM-producing culture (Streptomyces AS-400) and that this toxic effect was abolished in MKOM2), and which contains the N-terminal portion, may indicate that the latter might have been synthesized by MKOM-producing culture as a possible mechanism for self protection against the toxic effect of the CYST-moiety in the molecule. This toxicity masking effect of the N-terminal portion could also be seen from the MTCs and MICs of the various compounds (Table 1) . That the 4 compounds tested, although very closely related, showed different inhibitory activities is not an isolated phenomenon. WELCH et al12) and REEDY et al13) observed marked differences in the growth inhibitory activities of three closely related antibiotics, chlorotetracycline, oxytetracycline and tetracycline.
Due to the probability that the mutants obtained might have been permeability ones, the 4 inhibitors mentioned above were tested for their ability to inhibit the puromycin reaction with the ribosome-bound nascent peptides formed under the direction of natural mRNA. Chlorotetracycline, known to inhibit the codon-directed binding of amino acyl-tRNA to ribosomes14), and chloramphenicol, known to bind to peptidyl transferase and directly inhibits the enzyme in puromycin reaction4,15), were used as control inhibitors.
The results obtained (Table 3) show that neither chlorotetracycline nor ox-MKOM and ox-CYST inhibited the puromycin reaction while MKOM and CYST were potent inhibitors (71.82 % and 88.2% Table 3 Under the experimental conditions adopted, peptidyl-tRNA would have been bound to either site A or P on to ribosomess5). Puromycin can only react with peptidyl-tRNA bound at site P. Inhibition of this reaction would thus indicate an inhibition of the enzyme peptidyl transferase3,16) Based on these results it is logical to conclude that MKOM and CYST exert their inhibitory action through inhibiting peptidyl transferase activity. This enzyme is an integral part of 50S subunit of ribosomes3).
That chlorotetracycline failed to inhibit the puromycin reaction was not unexpected since this antibiotic acts on the 30S subunit and thus would be unable to block the puromycin reaction.
The results obtained with ox-MKOM and ox-CYST (Table 3) It is unlikely, however, that these compounds might have stimulated the translocation reaction in the light of the fact that the reaction system used was lacking in GTP which is essential for translocation to occur"'. In addition, the possibility that ox-MKOM and ox-CYST might have exerted their effect in a similar way to that of puromycin is ruled out in the light of the failure of these compounds to release the ribosome-bound peptides under the same conditions used for puromycin reaction. Using the methods of NATHANs18), the peptides released in the systems containing puromycin and each of these compounds were found all of peptidyl-puromycin and none as peptidylderivatives of these compounds. Hydrolysis of the released peptides with 6N HCl at 110°C for 20 hours released no taurine which is a main component of the compounds tested.
Addition of chloramphenicol (Table 3) , the second control inhibitor, resulted in the inhibition of puromycin reaction by 79.46%compared with the controls. Almost complete inhibition of puromycin reaction could be recorded when a mixture of chloramphenicol and either MKOM or CYST was present together with puromycin in the reaction system. Since chloramphenicol inhibits peptidyl transferase4,15)and that its action was intensified by MKOM and CYST, it is thus logical to assume that these compounds might have the same mode of action. Addition of ox-MKOM or ox-CYST to the chloramphenicol-containing system had reduced its inhibitory action on puromycin reaction from 79.46 % to 30.19 % and to 42.73 % respectively. Similar results were obtained when the oxidized compounds were added to the MKOM-or CYST-containing systems (Table 3) . These results would indicate that the oxidized compounds might have affected the inhibitory action of chloramphenicol, MKOM and CYST by probably competing for binding on the sensitive site(s) in the molecule of peptidyl transferase and/or through unknown mechanism.
The mode of action of the various compounds was further investigated by studying their effects on the in vitro protein synthesis. The amino acids incorporation mixture was prepared4) and incubation was conducted for 5 minutes at 37°C in the presence and absence of the compounds investigated.
Incorporation of amino acids in protein was directed by the natural mRNA of the extract. The ribosomes were then sedimented from the incorporation mixture, washed and the released nascent peptides from puromycin-treated ribosomes were estimated. From the corresponding results (Table  4) it is clear that MKOM and CYST are potent inhibitors for the in vitro protein synthesis by ribosomes while their ox-forms have activated this process. Addition of ox-MKOM or ox-CYST to MKOMor CYST-containing systems had reduced the inhibitory action of the latter compounds by 33~38%, depending on the compound added.
The results obtained with the performic acid-oxidized substances were rather unexpected in light of the fact that the concentrations used were those of the minimum inhibitory ones. Using half, twice and three times these concentrations no change in the results could be observed. This would indicate that these compounds do not act on ribosomes. The bacterial growth in vivo might have been inhibited by interfering of these compounds with one or more of the other metabolic activities of the test organism. The exact mechanism of action of ox-MKOM and ox-CYST, and which differs from that of MKOM and CYST, was identified and described in a separate communication19).
Finally, it is worth pointing out that despite the efforts made to determine the full structural configuration of the part (X) in the compounds tested only limited information could be obtained but the exact location of the aliphatic acids1,2) could not yet been achieved.
